Healthequity (HQY) Stock Price
Healthequity Price
Revenue has compounded at 29.4% per year over the past 13 years to 1.31 B USD. Earnings per share have grown at 18.9% per year over the last 13 years. Healthequity's net margin stands at 16.4%, up from -5.9% several years earlier. Analysts set a median price target of 125.97 USD, implying 28.2% above the current price. Of 20 analysts, 17 rate the stock a buy — an overall Buy consensus. The stock trades about 34% above its 52-week low.
Healthequity stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Healthequity over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Healthequity stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Healthequity's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Healthequity Price |
|---|---|
| 7/27/2026 | 98.28 USD |
| 7/23/2026 | 94.33 USD |
| 7/22/2026 | 95.95 USD |
| 7/21/2026 | 97.77 USD |
| 7/20/2026 | 98.88 USD |
| 7/17/2026 | 97.67 USD |
| 7/16/2026 | 98.69 USD |
| 7/15/2026 | 95.07 USD |
| 7/14/2026 | 94.50 USD |
| 7/13/2026 | 95.29 USD |
| 7/10/2026 | 94.40 USD |
| 7/9/2026 | 94.81 USD |
| 7/8/2026 | 95.40 USD |
| 7/7/2026 | 96.98 USD |
| 7/6/2026 | 96.84 USD |
| 7/2/2026 | 95.31 USD |
| 7/1/2026 | 92.29 USD |
| 6/30/2026 | 90.32 USD |
| 6/29/2026 | 86.50 USD |
| 6/26/2026 | 88.46 USD |
| 6/25/2026 | 83.43 USD |
| 6/24/2026 | 85.00 USD |
| 6/23/2026 | 84.92 USD |
| 6/22/2026 | 84.64 USD |
| 6/18/2026 | 84.99 USD |
| 6/17/2026 | 85.60 USD |
| 6/16/2026 | 85.87 USD |
| 6/15/2026 | 86.58 USD |
| 6/12/2026 | 87.42 USD |
| 6/11/2026 | 88.26 USD |
| 6/10/2026 | 89.78 USD |
| 6/9/2026 | 89.23 USD |
| 6/8/2026 | 87.84 USD |
| 6/5/2026 | 87.67 USD |
| 6/4/2026 | 88.10 USD |
| 6/3/2026 | 85.32 USD |
| 6/2/2026 | 88.21 USD |
| 6/1/2026 | 90.81 USD |
| 5/29/2026 | 89.16 USD |
| 5/28/2026 | 89.56 USD |
| 5/27/2026 | 88.08 USD |
| 5/26/2026 | 87.38 USD |
| 5/22/2026 | 86.93 USD |
| 5/21/2026 | 86.01 USD |
| 5/20/2026 | 85.86 USD |
| 5/19/2026 | 84.65 USD |
| 5/18/2026 | 83.04 USD |
| 5/15/2026 | 82.17 USD |
| 5/14/2026 | 82.32 USD |
| 5/13/2026 | 82.18 USD |
| 5/12/2026 | 80.46 USD |
| 5/11/2026 | 81.65 USD |
| 5/8/2026 | 84.84 USD |
| 5/7/2026 | 83.99 USD |
| 5/6/2026 | 83.25 USD |
| 5/5/2026 | 82.63 USD |
| 5/4/2026 | 82.18 USD |
| 5/1/2026 | 82.40 USD |
| 4/30/2026 | 82.03 USD |
| 4/29/2026 | 81.48 USD |
| 4/28/2026 | 81.18 USD |
| 4/27/2026 | 83.52 USD |
| 4/24/2026 | 82.45 USD |
| 4/23/2026 | 77.75 USD |
| 4/22/2026 | 82.88 USD |
| 4/21/2026 | 84.30 USD |
| 4/20/2026 | 86.33 USD |
| 4/17/2026 | 86.04 USD |
| 4/16/2026 | 84.53 USD |
| 4/15/2026 | 83.67 USD |
| 4/14/2026 | 81.36 USD |
| 4/13/2026 | 79.91 USD |
| 4/10/2026 | 77.96 USD |
| 4/9/2026 | 84.20 USD |
| 4/8/2026 | 81.95 USD |
| 4/7/2026 | 81.08 USD |
| 4/6/2026 | 83.44 USD |
| 4/5/2026 | 83.44 USD |
| 4/2/2026 | 84.67 USD |
| 4/1/2026 | 84.67 USD |
| 3/31/2026 | 83.38 USD |
| 3/30/2026 | 83.57 USD |
| 3/29/2026 | 81.48 USD |
| 3/27/2026 | 82.51 USD |
| 3/26/2026 | 82.51 USD |
| 3/25/2026 | 83.85 USD |
| 3/24/2026 | 82.47 USD |
| 3/23/2026 | 82.10 USD |
| 3/22/2026 | 81.64 USD |
| 3/20/2026 | 81.02 USD |
| 3/19/2026 | 81.02 USD |
| 3/18/2026 | 81.13 USD |
| 3/17/2026 | 79.57 USD |
| 3/16/2026 | 79.40 USD |
| 3/15/2026 | 78.67 USD |
| 3/13/2026 | 77.81 USD |
| 3/12/2026 | 77.81 USD |
| 3/11/2026 | 76.79 USD |
| 3/10/2026 | 78.57 USD |
| 3/9/2026 | 78.50 USD |
| 3/8/2026 | 80.04 USD |
| 3/6/2026 | 78.36 USD |
| 3/5/2026 | 79.96 USD |
| 3/4/2026 | 81.15 USD |
| 3/3/2026 | 80.43 USD |
| 3/2/2026 | 77.93 USD |
| 2/27/2026 | 76.49 USD |
| 2/26/2026 | 77.39 USD |
| 2/25/2026 | 75.56 USD |
| 2/24/2026 | 75.89 USD |
| 2/23/2026 | 75.87 USD |
| 2/20/2026 | 78.90 USD |
| 2/19/2026 | 78.88 USD |
| 2/18/2026 | 77.11 USD |
| 2/17/2026 | 74.36 USD |
| 2/13/2026 | 73.88 USD |
| 2/12/2026 | 73.88 USD |
| 2/11/2026 | 73.21 USD |
| 2/10/2026 | 76.92 USD |
| 2/9/2026 | 78.35 USD |
| 2/8/2026 | 79.28 USD |
| 2/6/2026 | 79.45 USD |
| 2/5/2026 | 79.45 USD |
| 2/4/2026 | 79.22 USD |
| 2/3/2026 | 81.34 USD |
| 2/2/2026 | 82.12 USD |
| 2/1/2026 | 87.07 USD |
| 1/30/2026 | 85.67 USD |
| 1/29/2026 | 85.67 USD |
| 1/28/2026 | 83.57 USD |
| 1/27/2026 | 82.85 USD |
| 1/26/2026 | 83.02 USD |
| 1/25/2026 | 85.33 USD |
| 1/23/2026 | 84.11 USD |
| 1/22/2026 | 84.11 USD |
| 1/21/2026 | 86.42 USD |
| 1/20/2026 | 84.59 USD |
| 1/19/2026 | 84.00 USD |
| 1/16/2026 | 85.37 USD |
| 1/15/2026 | 85.37 USD |
| 1/14/2026 | 86.94 USD |
| 1/13/2026 | 85.60 USD |
| 1/12/2026 | 84.28 USD |
| 1/11/2026 | 84.56 USD |
| 1/9/2026 | 94.15 USD |
| 1/8/2026 | 94.15 USD |
| 1/7/2026 | 98.51 USD |
| 1/6/2026 | 97.77 USD |
| 1/5/2026 | 95.45 USD |
| 1/4/2026 | 93.47 USD |
| 1/2/2026 | 91.07 USD |
| 1/1/2026 | 91.07 USD |
| 12/31/2025 | 91.61 USD |
| 12/30/2025 | 91.61 USD |
| 12/29/2025 | 92.50 USD |
| 12/28/2025 | 92.78 USD |
| 12/26/2025 | 93.48 USD |
| 12/25/2025 | 93.48 USD |
| 12/24/2025 | 92.45 USD |
| 12/23/2025 | 92.45 USD |
| 12/22/2025 | 92.69 USD |
| 12/21/2025 | 93.78 USD |
| 12/19/2025 | 95.50 USD |
| 12/18/2025 | 95.50 USD |
| 12/17/2025 | 95.50 USD |
| 12/16/2025 | 95.31 USD |
| 12/15/2025 | 96.00 USD |
| 12/14/2025 | 95.75 USD |
| 12/12/2025 | 96.79 USD |
| 12/11/2025 | 96.79 USD |
| 12/10/2025 | 97.39 USD |
| 12/9/2025 | 95.73 USD |
| 12/8/2025 | 93.26 USD |
| 12/7/2025 | 92.09 USD |
| 12/5/2025 | 94.51 USD |
| 12/4/2025 | 94.51 USD |
| 12/3/2025 | 95.67 USD |
| 12/2/2025 | 98.64 USD |
| 12/1/2025 | 98.88 USD |
| 11/30/2025 | 102.41 USD |
| 11/28/2025 | 105.18 USD |
| 11/27/2025 | 105.18 USD |
| 11/26/2025 | 104.99 USD |
| 11/25/2025 | 104.99 USD |
| 11/24/2025 | 105.44 USD |
| 11/23/2025 | 103.64 USD |
| 11/21/2025 | 101.91 USD |
| 11/20/2025 | 101.91 USD |
| 11/19/2025 | 100.73 USD |
| 11/18/2025 | 103.55 USD |
| 11/17/2025 | 102.74 USD |
| 11/16/2025 | 100.17 USD |
| 11/14/2025 | 101.77 USD |
| 11/13/2025 | 101.77 USD |
| 11/12/2025 | 99.50 USD |
| 11/11/2025 | 100.50 USD |
| 11/10/2025 | 99.83 USD |
| 11/9/2025 | 99.83 USD |
| 11/7/2025 | 93.71 USD |
| 11/6/2025 | 93.71 USD |
| 11/5/2025 | 92.74 USD |
| 11/4/2025 | 94.39 USD |
| 11/3/2025 | 95.04 USD |
| 11/2/2025 | 94.81 USD |
| 10/31/2025 | 94.58 USD |
| 10/30/2025 | 94.58 USD |
| 10/29/2025 | 92.95 USD |
| 10/28/2025 | 94.44 USD |
| 10/27/2025 | 95.15 USD |
| 10/26/2025 | 96.17 USD |
| 10/23/2025 | 96.50 USD |
| 10/22/2025 | 96.34 USD |
| 10/21/2025 | 95.48 USD |
| 10/20/2025 | 96.00 USD |
| 10/19/2025 | 93.03 USD |
| 10/16/2025 | 91.46 USD |
| 10/15/2025 | 91.04 USD |
| 10/14/2025 | 92.55 USD |
| 10/13/2025 | 94.04 USD |
| 10/12/2025 | 93.23 USD |
| 10/9/2025 | 90.52 USD |
| 10/8/2025 | 92.78 USD |
| 10/7/2025 | 92.09 USD |
| 10/6/2025 | 88.50 USD |
| 10/5/2025 | 87.78 USD |
| 10/2/2025 | 88.59 USD |
| 10/1/2025 | 89.68 USD |
| 9/30/2025 | 90.71 USD |
| 9/29/2025 | 94.77 USD |
| 9/28/2025 | 95.34 USD |
| 9/25/2025 | 96.53 USD |
| 9/24/2025 | 96.16 USD |
| 9/23/2025 | 94.26 USD |
| 9/22/2025 | 93.85 USD |
| 9/21/2025 | 95.97 USD |
| 9/18/2025 | 93.74 USD |
| 9/17/2025 | 95.59 USD |
| 9/16/2025 | 92.28 USD |
| 9/15/2025 | 91.54 USD |
| 9/14/2025 | 93.02 USD |
| 9/11/2025 | 92.49 USD |
| 9/10/2025 | 92.34 USD |
| 9/9/2025 | 91.51 USD |
| 9/8/2025 | 92.99 USD |
| 9/7/2025 | 93.06 USD |
| 9/4/2025 | 91.48 USD |
| 9/3/2025 | 97.70 USD |
| 9/2/2025 | 95.54 USD |
| 9/1/2025 | 88.85 USD |
| 8/28/2025 | 89.33 USD |
| 8/27/2025 | 88.29 USD |
| 8/26/2025 | 87.98 USD |
| 8/25/2025 | 89.33 USD |
| 8/24/2025 | 87.42 USD |
| 8/21/2025 | 89.82 USD |
| 8/20/2025 | 91.06 USD |
| 8/19/2025 | 89.04 USD |
| 8/18/2025 | 89.93 USD |
| 8/17/2025 | 89.53 USD |
| 8/14/2025 | 89.89 USD |
| 8/13/2025 | 87.43 USD |
| 8/12/2025 | 89.27 USD |
| 8/11/2025 | 92.98 USD |
| 8/10/2025 | 92.46 USD |
| 8/7/2025 | 93.05 USD |
| 8/6/2025 | 91.84 USD |
| 8/5/2025 | 90.95 USD |
| 8/4/2025 | 91.01 USD |
| 8/3/2025 | 91.15 USD |
| 7/31/2025 | 91.06 USD |
| 7/30/2025 | 97.00 USD |
Healthequity Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Healthequity Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.06 | 0.09 | 0.13 | 0.18 | 0.23 | 0.29 | 0.53 | 0.73 | 0.76 | 0.86 | 1.00 | 1.20 | 1.31 | 1.42 | 1.52 | 1.63 |
| 34.78 | 40.32 | 44.83 | 41.27 | 28.65 | 25.33 | 85.02 | 38.04 | 3.14 | 13.89 | 16.03 | 20.02 | 9.51 | 7.77 | 7.42 | 6.97 |
| 50.00 | 52.87 | 55.56 | 57.30 | 56.77 | 60.98 | 54.80 | 46.25 | 44.97 | 45.88 | 52.95 | 57.71 | 69.54 | 69.54 | 69.54 | 69.54 |
| 0.03 | 0.05 | 0.07 | 0.10 | 0.13 | 0.18 | 0.29 | 0.34 | 0.34 | 0.40 | 0.53 | 0.69 | 0.91 | 0.98 | 1.06 | 1.13 |
| 11.00 | 16.00 | 26.00 | 41.00 | 54.00 | 77.00 | 62.00 | 80.00 | 40.00 | 37.00 | 129.00 | 230.00 | 322.00 | 715.00 | 769.00 | 822.00 |
| 17.74 | 18.39 | 20.63 | 23.03 | 23.58 | 26.83 | 11.68 | 10.91 | 5.29 | 4.30 | 12.91 | 19.18 | 24.52 | 50.53 | 50.59 | 50.55 |
| 1.00 | 10.00 | 16.00 | 26.00 | 47.00 | 73.00 | 39.00 | 8.00 | -44.00 | -26.00 | 55.00 | 96.00 | 215.00 | 403.00 | 465.00 | 512.00 |
| -90.91 | 900.00 | 60.00 | 62.50 | 80.77 | 55.32 | -46.58 | -79.49 | -650.00 | -40.91 | -311.54 | 74.55 | 123.96 | 87.44 | 15.38 | 10.11 |
| 57.55 | 59.26 | 60.07 | 61.87 | 63.92 | 70.52 | 77.85 | 83.55 | 84.57 | 87.12 | 88.63 | 86.97 | 85.01 | 85.01 | 85.01 | 85.01 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Healthequity generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Healthequity retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Healthequity's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Healthequity has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Healthequity's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Healthequity stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Healthequity Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Healthequity business model & stock analysis
Healthequity SWOT Analysis
Strengths
Healthequity Inc has a strong market position with a well-established brand in the healthcare industry. The company has a solid track record of financial performance, evidenced by consistent revenue growth and profitability. Its robust technology platform provides user-friendly and secure healthcare account management solutions, which have been widely adopted by both individuals and employers.
Healthequity's extensive network of partnerships with healthcare providers and insurance companies further strengthens its competitive advantage. This enables the company to offer a wide range of healthcare services and benefits to its customers, enhancing their overall experience and satisfaction.
Weaknesses
One potential weakness for Healthequity is its dependence on the US healthcare regulatory environment. Changes in healthcare policies and regulations may impact the company's operations and profitability. Additionally, since the company primarily operates in the United States, it faces limited geographical diversification, which exposes it to regional economic fluctuations and potential market saturation.
Maintaining customer trust and data security is crucial for Healthequity. Any breach or compromise in data privacy could not only harm the company's reputation but also lead to legal and financial consequences.
Opportunities
The rising healthcare costs and increasing awareness of the importance of personal healthcare management provide Healthequity with significant growth opportunities. The company can capitalize on this by expanding its product offerings and services, targeting both individual consumers and employer-sponsored plans.
Healthequity can explore partnerships and collaborations with other companies in the healthcare technology industry to leverage synergies and expand its market reach. Additionally, the growing trend of remote and virtual healthcare delivery presents an avenue for the company to develop innovative solutions and gain a competitive edge.
Threats
Competition within the healthcare technology sector poses a threat to Healthequity. Other established players and new entrants may offer similar services, potentially eroding the company's market share. The company must continuously innovate and differentiate itself to stay ahead in this rapidly evolving industry.
Economic downturns can negatively impact consumer spending on healthcare services, affecting Healthequity's revenue growth. Additionally, changes in healthcare policies and regulations, as well as political uncertainties, could introduce challenges and disrupt the company's operations.
Healthequity Segments
Healthequity Revenue by Segment
3 Years
5 Years
Max
Details
Healthequity Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Healthequity historical P/E ratio, EBIT multiple, and P/S ratio
Healthequity annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Healthequity shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Healthequity forecasts and price targets in July 2026
Analyst Price Targets 2026| Δ MOM Price Target | 0.00 % |
| Buy | 85.00 % (17) |
| Hold | 10.00 % (2) |
| Sell | 5.00 % (1) |
| 12M Price Target | 125.97 |
| Last Price | 103.39 |
| Currency | USD |
| 12M Return Potential | 21.85 % |
| LTM Return | 0 % |
Healthequity Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/28/2026 | 1.13USD | 355.38 MUSD | 2027 Q1 |
| 3/17/2026 | 0.91USD | 336.38 MUSD | 2026 Q4 |
| 12/3/2025 | 0.94USD | 324.24 MUSD | 2026 Q3 |
| 12/9/2024 | 0.73USD | 293.54 MUSD | 2025 Q3 |
| 12/3/2024 | 0.72USD | 292.82 MUSD | 2025 Q3 |
| 6/3/2024 | 0.68USD | 280.98 MUSD | 2025 Q1 |
| 3/19/2024 | 0.50USD | 259.91 MUSD | 2024 Q4 |
| 12/4/2023 | 0.45USD | 241.50 MUSD | 2024 Q3 |
| 6/5/2023 | 0.40USD | 238.13 MUSD | 2024 Q1 |
| 3/20/2023 | 0.32USD | 224.27 MUSD | 2023 Q4 |
EESG©
Eulerpool ESG Scorecard© for the Healthequity stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Healthequity shareholder structure
| % | Name |
|---|---|
11.16801% | |
9.92805% | |
7.14076% | |
5.20193% | |
3.72685% | |
2.63148% |
Healthequity Executives and Management Board
Mr. Scott Cutler
(55)President, Chief Executive Officer, Director · since 2025
Mr. Michael Fiore
(50)Executive Vice President, Chief Commercial Officer
Mr. James Lucania
(46)Executive Vice President, Chief Financial Officer
Mr. Elimelech Rosner
(68)Executive Vice President, Chief Technology Officer
Mr. Delano Ladd
(44)Executive Vice President, General Counsel
Frequently asked questions about Healthequity
Healthequity Inc operates as a leading provider of health savings accounts (HSAs) and other consumer-driven health financial services. The company's business model revolves around offering solutions that empower individuals to make informed healthcare decisions and take control of their financial well-being. Healthequity provides a comprehensive platform where individuals can save, spend, and invest healthcare dollars wisely. Through its technology-enabled services, Healthequity enables employers, benefits administrators, and health plans to reduce healthcare costs while offering employees a seamless and personalized experience. The company's commitment to innovation and customer-centricity drives its success in the healthcare financial industry.
Healthequity stock
Healthequity Peer Group
Healthequity Ticker
Healthequity FIGI
All fundamentals and in-depth analysis of Healthequity
Our stock analysis for Healthequity stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Healthequity. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.